120 related articles for article (PubMed ID: 9949632)
1. Reversal of bone marrow fibrosis in idiopathic myelofibrosis after treatment with alpha-interferon.
Domingues MA; Haepers AT; Massaut IH; Vassallo J; Lorand-Metze I
Haematologica; 1998 Dec; 83(12):1124-5. PubMed ID: 9949632
[TBL] [Abstract][Full Text] [Related]
2. [Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].
Kumas Sotiris ; Semenova EA; Turkina AG; Zakharova AV; Domracheva EV; Khoroshko ND; Frank GA
Arkh Patol; 2003; 65(4):9-12. PubMed ID: 14518186
[TBL] [Abstract][Full Text] [Related]
3. Imatinib mesylate in idiopathic and postpolycythemic myelofibrosis.
Hasselbalch HC; Bjerrum OW; Jensen BA; Clausen NT; Hansen PB; Birgens H; Therkildsen MH; Ralfkiaer E
Am J Hematol; 2003 Dec; 74(4):238-42. PubMed ID: 14635203
[TBL] [Abstract][Full Text] [Related]
4. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
[TBL] [Abstract][Full Text] [Related]
5. Juvenile myelomonocytic leukemia relapsing after allogeneic bone marrow transplantation successfully treated with interferon-alpha.
Ohta H; Kawai M; Sawada A; Tokimasa S; Fujisaki H; Matsuda Y; Osugi Y; Okada S; Hara J
Bone Marrow Transplant; 2000 Sep; 26(6):681-3. PubMed ID: 11041570
[TBL] [Abstract][Full Text] [Related]
6. Imatinib mesylate therapy reduces bone marrow fibrosis in patients with chronic myelogenous leukemia.
Bueso-Ramos CE; Cortes J; Talpaz M; O'Brien S; Giles F; Rios MB; Medeiros LJ; Kantarjian H
Cancer; 2004 Jul; 101(2):332-6. PubMed ID: 15241831
[TBL] [Abstract][Full Text] [Related]
7. [Successful induction and complete improvement of myelofibrosis and erythema nosodum with cladribine in a case of hairy cell leukemia].
Araki H; Matsunaga T; Murase K; Kuroda H; Kuribayashi K; Terui T; Niitsu Y
Gan To Kagaku Ryoho; 2004 Jun; 31(6):965-9. PubMed ID: 15222122
[TBL] [Abstract][Full Text] [Related]
8. Effect of 2-chlorodeoxyadenosine therapy on bone marrow fibrosis in hairy cell leukemia.
Dedic K; Zák P
Neoplasma; 2004; 51(1):56-8. PubMed ID: 15004661
[TBL] [Abstract][Full Text] [Related]
9. Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Bundschuh S; Biermann T; Roessler G; Wasmus M; Diehl V; Zankovich R; Schaefer HE
Am J Clin Pathol; 2000 Jul; 114(1):57-65. PubMed ID: 10884800
[TBL] [Abstract][Full Text] [Related]
10. Evolution of myelofibrosis in chronic idiopathic myelofibrosis as evidenced in sequential bone marrow biopsy specimens.
Buhr T; Büsche G; Choritz H; Länger F; Kreipe H
Am J Clin Pathol; 2003 Jan; 119(1):152-8. PubMed ID: 12520711
[TBL] [Abstract][Full Text] [Related]
11. Myelofibrosis with myeloid metaplasia: the advanced phase of an untreated disseminated hematological cancer. Time to change our therapeutic attitude with early upfront treatment?
Hasselbalch HC
Leuk Res; 2009 Jan; 33(1):11-8. PubMed ID: 18632152
[TBL] [Abstract][Full Text] [Related]
12. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
[TBL] [Abstract][Full Text] [Related]
13. [Improvement of bone marrow hematopoiesis in idiopathic myelofibrosis with prednisolone].
Tanosaki R; Uchida H; Masuda Y; Michikawa N; Ogawa T; Kubo A; Ikeda Y
Rinsho Ketsueki; 1992 Feb; 33(2):256-8. PubMed ID: 1635179
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of chronic myelogenous leukemia with imatinib mesylate resulting in hematological remission and marked regression of myelofibrosis].
Takahari D; Matsunaga T; Fujimi A; Kikuchi T; Seki R; Tanaka I; Takemoto N; Akiyama T; Sato T; Terui T; Kogawa K; Kato J; Kura T; Maeda T; Niitsu Y
Rinsho Ketsueki; 2002 Oct; 43(10):924-30. PubMed ID: 12462028
[TBL] [Abstract][Full Text] [Related]
15. Primary autoimmune myelofibrosis: definition of a distinct clinicopathologic syndrome.
Pullarkat V; Bass RD; Gong JZ; Feinstein DI; Brynes RK
Am J Hematol; 2003 Jan; 72(1):8-12. PubMed ID: 12508261
[TBL] [Abstract][Full Text] [Related]
16. Effects of interferon and hydroxyurea on bone marrow fibrosis in chronic myelogenous leukaemia: a comparative retrospective multicentre histological and clinical study.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Spohr M; Diehl V; Zankovich R; Niederle N; Leder LD
Br J Haematol; 2000 Jan; 108(1):64-71. PubMed ID: 10651725
[TBL] [Abstract][Full Text] [Related]
17. [Successful treatment of primary myelofibrosis with thrombocytosis during pregnancy with alfa-interferon].
Gotić M; Cvetković M; Bozanović T; Cemerikić V
Srp Arh Celok Lek; 2001; 129(11-12):304-8. PubMed ID: 11928616
[TBL] [Abstract][Full Text] [Related]
18. Myelofibrosis with myeloid metaplasia: therapeutic options in 2003.
Mesa RA
Curr Hematol Rep; 2003 May; 2(3):264-70. PubMed ID: 12901349
[TBL] [Abstract][Full Text] [Related]
19. Acquired resistance to interferon alpha therapy associated with homozygous MPL-W515L mutation and chromosome 20q deletion in primary myelofibrosis.
Buxhofer-Ausch V; Gisslinger H; Berg T; Gisslinger B; Kralovics R
Eur J Haematol; 2009 Feb; 82(2):161-3. PubMed ID: 19018861
[No Abstract] [Full Text] [Related]
20. [Beneficial effect of 1,25-dihydroxyvitamin D3 in the treatment of myelofibrosis].
Palomera L; García Díez I; Martínez R
Med Clin (Barc); 1989 Sep; 93(7):265-8. PubMed ID: 2811498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
